Osimertinib
astrazeneca
['impact,(-impacte),(-impacti),(-impactf)']
 until os/qol data are available, this option should be openly discussed w/ the patients themselves, w/ all its potential benefits &amp; consequences. they will be the best to judge the impact on their qol based on what we know today. regular trial updates help to navigate through it
Dedicated to science & management of cancer. Proud alumni of @RockefellerUniv & @ETH. Focus on Medical & #ThoracicOncology. Views = my own. RTs/Ls ? endorsement